The upregulation of two inflammatory biomarkers (C-reactive protein and soluble tumor necrosis factor receptor II) and its association with the progression of CKD have been observed in a large cohort of patients with myocardial infarction–induced CKD [24]. The gene discussed is CRP; the disease is chronic kidney disease.